Medical Design Technology

Orthopedics

Subscribe to Orthopedics

CareFusion Announces National Launch of Spinal Fracture Device

August 26, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Aug. 26 /- CareFusion (NYSE: CFN ), a leading, global medical device company, today announced the national commercial launch of the AVA max® Vertebral Balloon, a minimally invasive device for use during kyphoplasty, a procedure for treating spinal compression fractures....

DePuy Orthopaedics Voluntarily Recalls ASRâ„¢ Hip System

August 26, 2010 7:31 am | by Bio-Medicine.Org | News | Comments

WARSAW, Ind., Aug. 26 /- DePuy Orthopaedics, Inc., announced it is voluntarily recalling the ASRâ„¢ XL Acetabular System and DePuy ASRâ„¢ Hip Resurfacing System used in hip replacement surgery due to the number of patients who required a second hip replacement procedure, called a...

Carpenter’s Custom 465 Stainless Opens Doors to New Business for Veridiam’s Medical OEMs

August 25, 2010 5:57 am | by Carpenter Technology | Articles | Comments

A contract manufacturer servicing original equipment manufacturers in the endoscopy/arthroscopy, orthopedic, dental/orthodontic and vascular markets has been making significant inroads into selling machined components for medical blade applications over the last several years. This is partly because of its customers’ increased use of Custom 465 stainless, produced by Carpenter Technology Corp., Wyomissing, Pa.

Advertisement

BridgeHead Software Reveals: & #8216;Why Disaster Recovery Is Different In Healthcare & #8217;

August 25, 2010 2:32 am | by RealWire | News | Comments

Free whitepaper explains that an effective Healthcare Disaster Recovery strategy is dependent on a solid understanding of a hospital's applications and dataAshtead, UK and Woburn, MA, USA - August 25, 2010 - BridgeHead Software today released a whitepaper on Healthcare Disaster Recovery...

Finite Element Analysis Software Designed for Large Deformation Problems

August 23, 2010 7:48 am | Scientific Forming Technologies Corp. | Product Releases | Comments

The finite element analysis package, developed by Scientific Forming Technologies Corp., is specially designed for large deformation problems with complex contact.

Premier Members to Benefit from Full Line of Market-Leading Masimo rainbow Pulse CO-Oximetry Solutions with New Agreement

August 19, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Aug. 19 /- Masimo (Nasdaq: MASI ), the inventor of Masimo rainbow® Pulse CO-Oximetry™ , Masimo rainbow Acoustic Monitoring™ , and Masimo SET® Measure-Through Motion and Low Perfusion pulse oximetry , announces an expanded supplier agreement that adds...

Frost & Sullivan: Innovative Products and Technologies Strengthen U.S. Spinal Surgery Market

August 13, 2010 9:32 pm | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Aug. 12 /- As more and more patients become aware of the advantages of the advanced non-fusion spinal surgery techniques, the negatives of the spinal fusion market become more obvious to the end users. In the next five years, the industry expects to see a steady...

Chinese orthopedic implant maker plans IPO

August 9, 2010 10:45 am | by The Associated Press | News | Comments

Orthopedic implant maker China Kanghui Holdings wants to raise $87 million in an initial public offering of its stock expected this week.The Chinese company plans to offer about 6.7 million American Depository shares, including 1.3 million offered by selling shareholders, priced between an...

Advertisement

CardioTec Conference to Address Opportunities and Challenges in Cardiovascular Device Manufacturing

August 4, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

RAMSEY, N.J. , Aug. 4 /- CardioTec is the first and only conference dedicated to addressing the challenges facing the cardiovascular device manufacturing industry. Hosted by Medical Product Outsourcing magazine, CardioTec invites OEM professionals and contract manufacturers/suppliers to...

PolyGel® Receives SADMERC Approval for L-Code L3670 for ThermoActive™ Cold & Hot Mobile Compression Shoulder Orthosis

August 4, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

WHIPPANY, N.J. , Aug. 4 /- PolyGel® is proud to announce that their ThermoActive ™ Cold & Hot Mobile Compression Shoulder Orthosis has been SADMERC – approved for L-Code L3670. (Photo: http://photos.prnewswire.com/prnh/20100804/NY45060 ) (Photo: http://w...

GHX to Present Strategies to Optimize Procurement, Especially of Physician Preference Items, at Annual AHRMM Conference

July 30, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

LOUISVILLE, Colo. , July 30 /- One of the biggest challenges faced by healthcare providers today is gaining control of the purchase of physician preference items (PPI), such as orthopedic implants, cardiac stents, pacemakers and other advanced medical devices, which can be among the most...

FDA panel recommends Medtronic spinal implant

July 28, 2010 10:45 am | by The Associated Press | News | Comments

A Food and Drug Administration advisory panel has recommended clearance for Medtronic's spin implant Amplify.The FDA's Orthopedic and Rehabilitation Devices Panel vote 6-to-5 in favor of the device, which stimulates bone growth in spinal surgery patients. The FDA normally follows the advice of...

Texas Health Plano, Texas Back Institute Offer SpineAssist Surgical Robot for Spine Surgeries

July 28, 2010 5:39 am | by Bio-Medicine.Org | News | Comments

Internationally renowned Plano surgeon co-invented technology PLANO, Texas , July 28 /PRNewswire-USNewswire/ -- Fifteen-year-old Tressa Scott of Allen hasn't been able to stand up straight for more than a year - until now. The Allen teenager grew an inch and a half and gained a...

Health Robotics Surpasses 100 Installations Milestone and Acquires Two I.V. Room of the Future Partner Companies

July 27, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

BOZEN, SUD-TIROL, Italy , July 27, 2010 /- Health Robotics announced that it has reached final agreements to acquire all assets from Italy -based MEDarchiver S.r.l. and Biomedical Technology Consulting S.r.l., merging these companies' employees and operations, re-entering direct sales...

Abbott to Feature Novel Tests and New Upgrades to Testing Platforms at American Association for Clinical Chemistry Lab Expo

July 26, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

ANAHEIM, Calif. , July 26 /- A first-of-its-kind test that detects HIV infection earlier than ever before in the United States ; a molecular assay for identification of two common sexually transmitted diseases; and an enhanced integrated analyzer offering significant workflow...

Calibra Gains FDA Clearance to Market Finesse™ Insulin Patch-Pen for Three-Day Use With Novolog®

July 26, 2010 7:35 am | by Bio-Medicine.Org | News | Comments

REDWOOD CITY, Calif. , July 26 /- Calibra Medical announced today it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Finesse™ insulin patch-pen for up to three-day use with Novo Nordisk's Novolog ® rapid acting insulin. Combining the...

SemBiosys expands into Cambridge

July 21, 2010 9:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

SemBioSys Genetics Inc., a Calgary, Alberta, based developer of biosimilar drug candidates, proteins and oils, reports that it is opening a Cambridge office, and hiring a president of U.S. and international operations.

Mitralign draws $5 million credit from GE Capital

July 19, 2010 6:32 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

GE Capital Healthcare Services has provided Tewksbury-based medical device company Mitralign Inc. with a $5 million secured credit facility that Mitralign will use for working capital as it advances development of its mitral valve repair device.

BD Biosciences Introduces CD4 Testing Product That Does Not Require Refrigeration

July 19, 2010 7:34 am | by Becton, Dickinson and Company | News | Comments

(July 19, 2010) -- BD Biosciences, a segment of BD (Becton, Dickinson and Company), today announced the creation of new dried reagents developed through a collaboration with ReaMetrix, a private biotechnology company based in Bangalore, India.  The new reagent

HIV testing should be routine in cancer care

July 18, 2010 12:33 am | by Baylor College of Medicine | News | Comments

In 2006, the U.S. Centers for Disease Control and Prevention recommended routine HIV testing in all healthcare settings as long as patients are given the opportunity to 'opt-out' or refuse the test. That recommendation is not widely followed, but it should be – especially in...

Lotus Pharmaceuticals to Present at Global Hunter Securities 2010 China Conference

July 7, 2010 5:34 am | by Bio-Medicine.Org | News | Comments

BEIJING , July 7 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China (the "PRC"), today announced it will present at the...

Tengion Appoints Sunita B. Sheth, M.D., Chief Medical Officer

July 7, 2010 5:34 am | by Bio-Medicine.Org | News | Comments

EAST NORRITON, Pa. , July 7 /- Tengion Inc. (Nasdaq: TNGN ) today announced that it has appointed Sunita B. Sheth , M.D., to the position of Chief Medical Officer, Vice President, Clinical and Regulatory Affairs. In this role, Dr. Sheth will be responsible for developing clinical...

Targegen Acquisition Could Be Worth as Much as $560M

July 1, 2010 11:32 am | by San Diego Business Journal | News | Comments

Targegen Inc., a San Diego biotech developing a drug to treat blood diseases, agreed to be acquired by Sanofi-Aventis, a French public company for what could be $560 million if the company reaches certain milestones.

Tolerx Presents Preclinical Data on Novel T-cell Modulator, TRX518, for Antitumor Immune Response at Federation of Clinical Immunology Societies Scientific Meeting

June 25, 2010 6:34 am | by Bio-Medicine.Org | News | Comments

CAMBRIDGE, Mass. , June 25 /- Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, presented results from preclinical studies with TRX518, an early-stage agent Tolerx is developing as a treatment for...

St. Jude wins European approval for cardiac ablation system

June 17, 2010 7:38 am | by Mass Device | News | Comments

St. Jude Medical Inc. lands European regulatory approval for a cardiac ablation system used to correct arrhythmias. By Brandon Glenn St. Jude Medical Inc. (NYSE:STJ) received European regulatory approval for a cardiac ablation system used in procedures to destroy diseased...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading